Skip to main content
SpringerLink
Log in

Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Glucocorticoid-induced diabetes mellitus (GDM) is a major complication arising from corticosteroid administration, but there is lack of studies on GDM attributing to CHOP chemotherapy. We studied the incidence and risk factors for GDM development in patients with lymphoma during CHOP chemotherapy.

Methods

We analyzed 80 patients with lymphoma treated with a CHOP regimen with or without rituximab between 2004 and 2012 at the University of Tsukuba hospital. Patients with a known history of DM were excluded. Diagnosis of DM was performed according to the American Diabetes Association’s criteria.

Results

Among the 80 patients, 26 (32.5 %) developed GDM. We found that age ≥60 years, glycated hemoglobin (HbA1c) levels >6.1 %, body mass index (BMI) >30 kg/m2, prednisolone administration prior to chemotherapy, history of hypertension or hypertension at admission, and the presence of metabolic syndrome were significant (p ≤ 0.05) factors associated with GDM development by univariate analysis. Multivariate analysis revealed that age ≥60 years [p < 0.05; hazard ratio (HR) = 3.59; 95 % confidence interval (CI), 1.22–10.51], HbA1c levels >6.1 % (p < 0.05; HR = 9.35; 95%CI, 1.45–60.34), and BMI >30 kg/m2 (p = 0.052; HR = 6.27; 95%CI, 0.98–40.00) were independently significant association factors.

Conclusion

The results suggest a guideline for plasma glucose monitoring during CHOP chemotherapy in patients with no history of DM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fardet L, Flahault A, Kettaneh A, Tiev KP, Genereau T, Toledano C, Lebbe C, Cabane J (2007) Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion. Br J Dermatol 157(1):142–148. doi:10.1111/j.1365-2133.2007.07950.x

    Article  PubMed  CAS  Google Scholar 

  2. Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, Zink A, Buttgereit F (2009) Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 68(7):1119–1124. doi:10.1136/ard.2008.092163

    Article  PubMed  CAS  Google Scholar 

  3. Wei L, MacDonald TM, Walker BR (2004) Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141(10):764–770

    Article  PubMed  Google Scholar 

  4. Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112(5):352–364

    Article  PubMed  CAS  Google Scholar 

  5. Wolkowitz OM, Burke H, Epel ES, Reus VI (2009) Glucocorticoids. Mood, memory, and mechanisms. Ann N Y Acad Sci 1179:19–40. doi:10.1111/j.1749-6632.2009.04980.x

    Article  PubMed  CAS  Google Scholar 

  6. Dixon WG, Abrahamowicz M, Beauchamp ME, Ray DW, Bernatsky S, Suissa S, Sylvestre MP (2012) Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis 71(7):1128–1133. doi:10.1136/annrheumdis-2011-200702

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Ferris HA, Kahn CR (2012) New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it. J Clin Invest 122(11):3854–3857. doi:10.1172/JCI66180

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. Cristancho AG, Lazar MA (2011) Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12(11):722–734. doi:10.1038/nrm3198

    Article  PubMed  CAS  Google Scholar 

  9. Mazziotti G, Gazzaruso C, Giustina A (2011) Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol Metab 22(12):499–506. doi:10.1016/j.tem.2011.09.001

    Article  PubMed  CAS  Google Scholar 

  10. Spenney JG, Eure CA, Kreisberg RA (1969) Hyperglycemic, hyperosmolar, nonketoacidotic diabetes. A complication of steroid and immunosupressive therapy. Diabetes 18(2):107–110

    PubMed  CAS  Google Scholar 

  11. Arner P, Gunnarsson R, Blomdahl S, Groth CG (1983) Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care 6(1):23–25

    Article  PubMed  CAS  Google Scholar 

  12. Hjelmesaeth J, Hartmann A, Kofstad J, Stenstrom J, Leivestad T, Egeland T, Fauchald P (1997) Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 64(7):979–983

    Article  PubMed  CAS  Google Scholar 

  13. Silva F, Queiros J, Vargas G, Henriques A, Sarmento A, Guimaraes S (2000) Risk factors for posttransplant diabetes mellitus and impact of this complication after renal transplantation. Transplant Proc 32(8):2609–2610

    Article  PubMed  CAS  Google Scholar 

  14. Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE (1999) Incidence and cost of steroid side effects after renal transplantation. Transplant Proc 31(1–2):301–302

    Article  PubMed  CAS  Google Scholar 

  15. Kamar N, Mariat C, Delahousse M, Dantal J, Al Najjar A, Cassuto E, Lefrancois N, Cointault O, Touchard G, Villemain F, Di Giambattista F, Benhamou PY, Diapason Study G (2007) Diabetes mellitus after kidney transplantation: a French multicentre observational study. Nephrol Dial Transplant 22(7):1986–1993. doi:10.1093/ndt/gfm011

    Article  PubMed  Google Scholar 

  16. Joss N, Staatz CE, Thomson AH, Jardine AG (2007) Predictors of new onset diabetes after renal transplantation. Clin Transplant 21(1):136–143. doi:10.1111/j.1399-0012.2006.00580.x

    Article  PubMed  Google Scholar 

  17. Hur KY, Kim MS, Kim YS, Kang ES, Nam JH, Kim SH, Nam CM, Ahn CW, Cha BS, Kim SI, Lee HC (2007) Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care 30(3):609–615. doi:10.2337/dc06-1277

    Article  PubMed  Google Scholar 

  18. Shah T, Kasravi A, Huang E, Hayashi R, Young B, Cho YW, Bunnapradist S (2006) Risk factors for development of new-onset diabetes mellitus after kidney transplantation. Transplantation 82(12):1673–1676. doi:10.1097/01.tp.0000250756.66348.9a

    Article  PubMed  Google Scholar 

  19. Ha Y, Lee KH, Jung S, Lee SW, Lee SK, Park YB (2011) Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy. Lupus 20(10):1027–1034. doi:10.1177/0961203311402246

    Article  PubMed  CAS  Google Scholar 

  20. den Uyl D, van Raalte DH, Nurmohamed MT, Lems WF, Bijlsma JW, Hoes JN, Dijkmans BA, Diamant M (2012) Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction. Arthritis Rheum 64(3):639–646. doi:10.1002/art.33378

    Article  CAS  Google Scholar 

  21. Gunnarsson R, Arner P, Lundgren G, Magnusson G, Ostman J, Groth CG (1977) Steroid diabetes after renal transplantation--a preliminary report. Scand J Urol Nephrol Suppl. (42):191-194

  22. Uzu T, Harada T, Sakaguchi M, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Koya D, Haneda M, Kashiwagi A, Yamauchi A (2007) Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases. Nephron Clin Pract 105(2):c54–c57. doi:10.1159/000097598

    Article  PubMed  CAS  Google Scholar 

  23. Mazali FC, Lalli CA, Alves-Filho G, Mazzali M (2008) Posttransplant diabetes mellitus: incidence and risk factors. Transplant Proc 40(3):764–766. doi:10.1016/j.transproceed.2008.03.018

    Article  PubMed  Google Scholar 

  24. Panthakalam S, Bhatnagar D, Klimiuk P (2004) The prevalence and management of hyperglycaemia in patients with rheumatoid arthritis on corticosteroid therapy. Scott Med J 49(4):139–141

    PubMed  CAS  Google Scholar 

  25. Stumvoll M, Goldstein BJ, van Haeften TW (2008) Type 2 diabetes: pathogenesis and treatment. Lancet 371(9631):2153–2156. doi:10.1016/S0140-6736(08)60932-0

    Article  PubMed  Google Scholar 

  26. Prospective Studies C, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373(9669):1083–1096. doi:10.1016/S0140-6736(09)60318-4

    Article  Google Scholar 

  27. Storlien LH, Baur LA, Kriketos AD, Pan DA, Cooney GJ, Jenkins AB, Calvert GD, Campbell LV (1996) Dietary fats and insulin action. Diabetologia 39(6):621–631

    Article  PubMed  CAS  Google Scholar 

  28. Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46(1):3–10

    Article  PubMed  CAS  Google Scholar 

  29. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1(7285):785–789

    Article  PubMed  CAS  Google Scholar 

  30. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97(12):2859–2865. doi:10.1172/JCI118742

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  31. Shepherd PR, Kahn BB (1999) Glucose transporters and insulin action–implications for insulin resistance and diabetes mellitus. N Engl J Med 341(4):248–257. doi:10.1056/NEJM199907223410406

    Article  PubMed  CAS  Google Scholar 

  32. Kahn BB (1992) Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J Clin Invest 89(5):1367–1374. doi:10.1172/JCI115724

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  33. American Diabetes A (2011) Standards of medical care in diabetes–2011. Diabetes Care 34(Suppl 1):S11–S61. doi:10.2337/dc11-S011

    Article  CAS  Google Scholar 

  34. Gillet MJ (2009) International Expert Commitee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 32(7):1327–1334, Clin Biochem Rev 30(4):197–200

    Google Scholar 

  35. Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE (1994) Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 96(2):115–123

    Article  PubMed  CAS  Google Scholar 

  36. Hricik DE, Bartucci MR, Moir EJ, Mayes JT, Schulak JA (1991) Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients. Transplantation 51(2):374–377

    Article  PubMed  CAS  Google Scholar 

  37. Pidala J, Kim J, Kharfan-Dabaja MA, Nishihori T, Field T, Perkins J, Perez L, Fernandez H, Anasetti C (2011) Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomes. Biol Blood Marrow Transplant 17(2):239–248. doi:10.1016/j.bbmt.2010.07.005

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

The authors report no conflicts of interest. No research support was provided for this study.

Author information

Authors and Affiliations

  1. Department of Hematology, Faculty of Medicine, University of Tsukuba, Tennodai 1-1-1, Tsukuba, 305-8575, Ibaraki, Japan

    Suk-young Lee, Naoki Kurita, Yasuhisa Yokoyama, Masanori Seki, Yuichi Hasegawa, Yasushi Okoshi & Shigeru Chiba

Authors
  1. Suk-young Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoki Kurita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuhisa Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masanori Seki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuichi Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasushi Okoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shigeru Chiba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shigeru Chiba.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, Sy., Kurita, N., Yokoyama, Y. et al. Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy. Support Care Cancer 22, 1385–1390 (2014). https://doi.org/10.1007/s00520-013-2097-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-013-2097-8

Keywords

Search

Navigation